CRISPR-GEMM Pooled Mutagenic Screening Identifies KMT2D as a Major Modulator of Immune Checkpoint Blockade
CRISPR-GEMM 联合诱变筛选鉴定出 KMT2D 是免疫检查点阻断的主要调节剂
期刊:Cancer Discovery
影响因子:29.7
doi:10.1158/2159-8290.CD-19-1448
Guangchuan Wang #, Ryan D Chow #, Lvyun Zhu #, Zhigang Bai #, Lupeng Ye, Feifei Zhang, Paul A Renauer, Matthew B Dong, Xiaoyun Dai, Xiaoya Zhang, Yaying Du, Yujing Cheng, Leilei Niu, Zhiyuan Chu, Kristin Kim, Cun Liao, Paul Clark, Youssef Errami, Sidi Chen